Tumour cell membrane laminin expression is associated with basal-like phenotype and poor survival in Nigerian breast cancer.
暂无分享,去创建一个
I. Ellis | E. Rakha | A. Green | C. Nolan | A. Agboola | H. Ebili | V. O. Iyawe | A. Banjo | B. Salami | E. Rakha | Ian O. Ellis | Andrew R. Green | Victoria O. Iyawe
[1] I. Ellis,et al. Molecular profiling of breast cancer in Nigerian women identifies an altered p53 pathway as a major mechanism underlying its poor prognosis compared with British counterpart. , 2014, The Malaysian journal of pathology.
[2] I. Ellis,et al. Helix-loop-helix protein inhibitor of differentiation 4 (ID4) expression is an indicator of poor survival in Nigerian breast cancer women , 2014 .
[3] O. Olopade,et al. Molecular subtypes of breast cancer , 2014 .
[4] I. Ellis,et al. Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women. , 2014, Pathology, research and practice.
[5] A. Tutt,et al. Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence? , 2012, Breast Cancer Research.
[6] W. Hop,et al. Tumour basement membrane laminin expression predicts outcome following curative resection of pancreatic head cancer , 2012, British Journal of Cancer.
[7] I. Ellis,et al. Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women , 2012, Breast Cancer Research and Treatment.
[8] Y. Im,et al. Clinical significance of CD151 overexpression in subtypes of invasive breast cancer , 2012, British Journal of Cancer.
[9] M. Petz,et al. La enhances IRES-mediated translation of laminin B1 during malignant epithelial to mesenchymal transition , 2011, Nucleic acids research.
[10] A. Chang. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. , 2011, Lung cancer.
[11] C. Adebamowo,et al. Emerging breast cancer epidemic: evidence from Africa , 2010, Breast Cancer Research.
[12] N. Wake,et al. Cytoplasmic and stromal expression of laminin γ 2 chain correlates with infiltrative invasion in ovarian mucinous neoplasms of gastro-intestinal type. , 2010, Oncology reports.
[13] F. Domann,et al. ZEB1 Coordinately Regulates Laminin-332 and β4 Integrin Expression Altering the Invasive Phenotype of Prostate Cancer Cells* , 2010, The Journal of Biological Chemistry.
[14] I. Ellis,et al. Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens , 2010, Histopathology.
[15] C. Perou,et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] E. Neilson,et al. Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.
[17] P. Yurchenco,et al. Developmental and pathogenic mechanisms of basement membrane assembly. , 2009, Current pharmaceutical design.
[18] M. Reed,et al. Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells. , 2008, Neoplasia.
[19] K. Tryggvason,et al. Laminin‐511 but Not ‐332, ‐111, or ‐411 Enables Mouse Embryonic Stem Cell Self‐Renewal In Vitro , 2008, Stem cells.
[20] R. Grenman,et al. Epithelial-mesenchymal transition downregulates laminin α5 chain and upregulates laminin α4 chain in oral squamous carcinoma cells , 2008, Histochemistry and Cell Biology.
[21] Ian O Ellis,et al. Basal-like breast cancer: a critical review. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] S. W. Lee,et al. MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene , 2008, Oncogene.
[23] Gema Moreno-Bueno,et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.
[24] E. Nice,et al. Evidence for a role of tumor-derived laminin-511 in the metastatic progression of breast cancer. , 2007, The American journal of pathology.
[25] A. Ashworth,et al. BRCA1 dysfunction in sporadic basal-like breast cancer , 2007, Oncogene.
[26] J. Benítez,et al. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas , 2006, Journal of Clinical Pathology.
[27] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2007, Archives of pathology & laboratory medicine.
[28] Abdul-Rasheed K. Adesunkanmi,et al. The severity, outcome and challenges of breast cancer in Nigeria. , 2006, Breast.
[29] N. M. Khazenzon,et al. Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. , 2006, Frontiers in bioscience : a journal and virtual library.
[30] Douglas G Altman,et al. Reporting recommendations for tumor marker prognostic studies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] T. Nardò,et al. Comparison of extracellular matrix and apoptotic markers between benign lesions and carcinomas in human breast. , 2005, International journal of oncology.
[32] E. Holler. Laminin isoform expression in breast tumors , 2005, Breast Cancer Research.
[33] 児玉 圭司. Laminin 5 expression protects against anoikis at aerogenous spread and lepidic growth of human lung adenocarcinoma , 2005 .
[34] 長戸 重幸. Downregulation of laminin α4 chain expression inhibits glioma invasion in vitro and in vivo , 2005 .
[35] N. M. Khazenzon,et al. Overexpression of β1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases , 2005, Breast Cancer Research.
[36] A. Gown,et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.
[37] N. M. Khazenzon,et al. Association between laminin‐8 and glial tumor grade, recurrence, and patient survival , 2004, Cancer.
[38] S. Ménard,et al. Prognostic significance of laminin production in relation with its receptor expression in human breast carcinomas , 1995, Breast Cancer Research and Treatment.
[39] R. Micciolo,et al. Prognostic Significance of Laminin, Laminin Receptor, and Bone Marrow Micrometastases in Breast Cancer Patients: Are These Markers of Aggressive Behavior and Metastatic Potential? , 2003, Applied immunohistochemistry & molecular morphology : AIMM.
[40] R. Fässler,et al. The role of laminin in embryonic cell polarization and tissue organization. , 2003, Developmental cell.
[41] C. Roskelley,et al. Regulation of BRCA1 expression and its relationship to sporadic breast cancer , 2002, Breast Cancer Research.
[42] J. Lohi. Laminin‐5 in the progression of carcinomas , 2001, International journal of cancer.
[43] M. Kedinger,et al. Overexpression of laminin α1 chain in colonic cancer cells induces an increase in tumor growth , 2001, International journal of cancer.
[44] A. Vecchione,et al. Implication of laminin and collagen type IV expression in the progression of breast carcinoma. , 2001, Anticancer research.
[45] P. J. Welch,et al. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[46] P. Yurchenco,et al. Form and function: The laminin family of heterotrimers , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.
[47] F. Martin,et al. Laminin-rich extracellular matrix association with mammary epithelial cells suppresses Brca1 expression , 2000, Cell Death and Differentiation.
[48] J. Nesland,et al. Laminin production and fibronectin immunoreactivity in breast carcinomas. , 1993, Anticancer research.
[49] S. Ménard,et al. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. , 1993, Journal of the National Cancer Institute.